Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013


Pharmaceutical Microbiology

30 Jan 2013 - 31 Jan 2013 - London, UK



Bookmark and Share


Book by 28th September and receive a £300 discount

Visit www.pharma-microbiology.com to claim your discount now!

Don’t miss SMi’s 2nd annual Pharmaceutical Microbiology conference that aims to provide an expert and highly accredited speaker line up including 13 pharma speakers who will focus on the latest developments and procedures used in the identification and prevention of contaminating agents, updates on new rules and regulations and the challenges facing the Pharmaceutical Microbiology industry. 

Reasons you should not miss this incredible event includes:

Discuss developments in tools, techniques and procedures used in identification and control of contaminants

Evaluate the handling of traditional drug and biologics & sterile product manufacturing 

Hear about design, construction and validation of sterile facilities and equipment

Engage with those currently working on producing the rapid microbial methods

Key Speakers include:

Oliver Chancel, Microbiologist, Sanofi-Aventis

Kim Bowers, Senior Scientist, Pfizer

Praful Bhusari, Associate Scientist, MedImmune

John Duguid, Principle Analytical Scientist, Genzyme

Scott Smith, Microbiology Team Leader, Sanofi-Aventis

Anne Warford, Associate Director, MedImmune

Amy McDaniel, Director, QC Microbiology, Pfizer

Stephen Rawling, Microbiology Team Leader, GlaxoSmithKline

Brendan Gilmore, Research Scientist, Queens University Belfast

Andrew Bartko, Senior Scientist, Battelle Research Institute

Hilary Chan, Quality Scientist IV, Pfizer  

Mark Thompson, Consultant, EPIC Consultancy & Training

Daniel Kockelkorn, Head of PKau Laboratory, Roche 

Emiliano Toso, Principle Scientist, Merck 

Gunther Meike, System Development Specialist, Charles River Laboratories

For more information contact Farhaana Rahman on +44 0 207 827 6186 or email frahman@smi-online.co.uk 



Further information
Scientific News
Combining Chemotherapy With Immune-Blocking Drug Could Stop Cancer Growing Back
Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people.
Researchers Pioneer Use of Capsules to Save Materials
Wax capsule delivery systems can simplify a wide range of chemistry transformations.
Photoredox Catalyst Unlocks New Pathways for Nickel Chemistry
Using a light-activated catalyst, researchers have unlocked a new pathway in nickel chemistry to construct carbon-oxygen (C-O) bonds that would be highly valuable to pharmaceutical and agrochemical industries.
Scientists Determine How Antibiotic Gains Cancer-Killing Sulfur Atoms
In a discovery with implications for future drug design scientists have shown an unprecedented mechanism for how a natural antibiotic with antitumor properties incorporates sulfur into its molecular structure, an essential ingredient of its antitumor activity.
Familiar Drugs May Block Ebola Virus Infection
A well-known class of molecules, many of which are already in use therapeutically, may be able to block the Ebola virus’s entry into cells and halt the disease in its tracks, according to researchers at the University of Illinois at Chicago.
New Extra ‘Sticky’ Microgel Could Revolutionise Bladder Cancer Treatment
Researchers have designed a new super-efficient way of delivering an anti-cancer drug which could extend and improve the quality of life for bladder cancer patients - and perhaps save lives.
Common Class of ‘Channel Blocking’ Drugs May Find a Role in Cancer Therapy
Discoveries in fruit flies prompt unusual treatment of patient with metastatic disease.
Common Medications Could Delay Brain Injury Recovery
Drugs used to treat common complaints could delay the recovery of brain injury patients according to research by University of East Anglia (UEA) and University of Aberdeen scientists, published today in Brain Injury.
Scientists Make Strides in Therapy Preventing Addiction Relapse
Single Injection of Drug Candidate Prevents Meth Relapse in Animal Models.
New Clot-Busting Treatments Target Number One Killer
Australian researchers funded by the National Heart Foundation are a step closer to a safer and more effective way to treat heart attack and stroke via nanotechnology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!